Pfizer has launched its 20-valent pneumococcal conjugate vaccine (PCV20) in India, offering single-dose protection against 20 ...

Construction on the site will begin in the fall and is expected to be finished by 2027. North Chicago is already home to ...

Parents in the United States who want to vaccinate their young children against Covid-19 this fall may face a growing set of ...

The potential move to rescind authorization of Pfizer's vaccine could leave some kids in the U.S. with no available shots ...

The Food and Drug Administration (FDA) may not re-authorize Pfizer's COVID vaccine for children under the age of 5, the ...

Padcev, an antibody-drug conjugate which Pfizer acquired via its $43 billion Seagen deal, could help people who don’t qualify ...

In search of a better approach to designing and developing these small proteins, researchers turned to ProtGPT2.

The FDA cautions the outcomes described in the complaints may have no connection to the drugs or could be unexpected side effects.

Merck's Phase 3 trial shows Keytruda plus Padcev improves survival in muscle-invasive bladder cancer patients ineligible for ...

Summit Therapeutics, which has consistently been communicating quarterly results through investor calls in the past few years ...

The research, done in mice and in human cells, shows that a protein called STUB1 restrains the immune system’s elite ...